Amneal Pharmaceuticals (AMRX) Accumulated Expenses (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Accumulated Expenses of $10.5 million for Q1 2026, down 75.75% year-over-year from $43.5 million in Q1 2025, and down 75.61% quarter-over-quarter from $43.3 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Accumulated Expenses (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $10.5 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 75.75% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (down 75.75% YoY), while the FY2025 annual figure was $43.3 million, up 36.22% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $10.5 million, down from $43.3 million in the prior quarter.
- The five-year high for Accumulated Expenses was $275.3 million in Q2 2022, with the low at $10.5 million in Q1 2026.
- The 5-year median for Accumulated Expenses is $43.4 million (2025), against an average of $73.0 million.
- The sharpest annual moves came in 2022 and 2026: Accumulated Expenses jumped 85.32% in 2022, then slumped 75.75% in 2026.
- Amneal Pharmaceuticals' Accumulated Expenses stood at $107.5 million in 2022, then slipped by 28.37% to $77.0 million in 2023, then sank by 58.75% to $31.8 million in 2024, then soared by 36.22% to $43.3 million in 2025, then sank by 75.61% to $10.5 million in 2026.
- Business Quant data shows AMRX's Accumulated Expenses at $10.5 million in Q1 2026, $43.3 million in Q4 2025, and $40.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.49 Mn |
| Mar 31, 2026 | 10.55 Mn |
| Dec 31, 2025 | 43.26 Mn |
| Sep 30, 2025 | 40.60 Mn |
| Jun 30, 2025 | 41.52 Mn |
| Mar 31, 2025 | 43.50 Mn |
| Dec 31, 2024 | 31.76 Mn |
| Sep 30, 2024 | 30.18 Mn |
| Jun 30, 2024 | 30.74 Mn |
| Mar 31, 2024 | 30.13 Mn |
| Dec 31, 2023 | 76.99 Mn |
| Sep 30, 2023 | 76.83 Mn |
| Jun 30, 2023 | 77.01 Mn |
| Mar 31, 2023 | 76.32 Mn |
| Dec 31, 2022 | 107.48 Mn |
| Sep 30, 2022 | 176.09 Mn |
| Jun 30, 2022 | 275.34 Mn |
| Dec 31, 2021 | 58.00 Mn |
| Dec 31, 2019 | 36.01 Mn |
| Dec 31, 2018 | 77.07 Mn |